The Food and Drug Administration (FDA) allegedly listened to several speakers on Friday at a hearing focused on the CBD, a cannabis compound that made its way into various consumer goods amid uncertainty about its legality. (AP Photo / Mark Lennihan)
The Food and Drug Administration (FDA) allegedly listened to several speakers on Friday at a hearing focused on the CBD, a cannabis compound that made its way into various consumer goods amid uncertainty about its legality.
The hearing was organized so that the agency can learn more about the CBD and consider whether its use in foods, beverages and dietary supplements can potentially be authorized, according to The Associated Press.
Current FDA guidelines do not allow CBD in any of the aforementioned products. But considering the limited resources of the agency, it is suspected that the FDA will not apply the guidelines unless the products make health claims that can put people at risk.
No decision is expected immediately, but the hearing is considered an important step in clarifying regulations on the ingredient, the paper said.
Some questions persist with regard to the safety of the CBD, said FDA Commissioner Ned Sharpless, and mentioned examples such as determining the acceptable daily dose.
Muscle Joint & Relief Cream is on display at the Cannabis World Congress & Business Exposition on Thursday in New York. (AP Photo / Mark Lennihan)
Other speakers, including academic researchers, businesses and consumer advocates, urged the FDA to act quickly, noting that the industry is growing rapidly and with little supervision.
CLICK HERE FOR THE FOX BUSINESS APP
The CBD often comes from a cannabis plant known as hemp, which the US government. UU It defines as less than 0.3% THC, the compound that causes the mental alteration effect of marijuana. The CBD does not cause that increase, but the fanatics of the products claim benefits that include relief for pain and anxiety.
The Associated Press contributed to this report.